Prozac appears to be no better than placebo for treating depression in children and teens; a new study proposes novelty bias and reduced expectancy effects as explanations for the loss of efficacy. 💊🧠📉
Read Full Article
#Prozac #DepressionInYouth #MentalHealthResearch #PlaceboEffect #Psychiatry
Read Full Article
#Prozac #DepressionInYouth #MentalHealthResearch #PlaceboEffect #Psychiatry
Journal of Clinical Epidemiology
The loss of efficacy of fluoxetine in pediatric depression: explanations, lack of acknowledgment, and implications for other treatments
Fluoxetine is among the most used antidepressants for children and adolescents and
frequently recommended as first-line pharmacological treatment for pediatric depression.
However, in contrast to earlier studies and reviews, a Cochrane network meta-analysis…
frequently recommended as first-line pharmacological treatment for pediatric depression.
However, in contrast to earlier studies and reviews, a Cochrane network meta-analysis…
🤔1💯1
Prozac ‘no better than placebo’ for treating children with depression, new review of trial data concluded. 📉 Clinical guidelines should change to avoid exposing young people to potentially harmful side-effects, researchers say. ⚠️🧑⚕️
Read Full Article
#Prozac #ChildMentalHealth #DepressionTreatment #ClinicalGuidelines #MentalHealthAwareness
Read Full Article
#Prozac #ChildMentalHealth #DepressionTreatment #ClinicalGuidelines #MentalHealthAwareness
😭3💯1